Literature DB >> 9462242

Mild abnormalities in liver histology associated with chronic hepatitis: distinction from normal liver histology.

E W Kay1, J O'Dowd, R Thomas, R Alyusuf, S Sachithanandan, R Robinson, C B Walsh, J F Fielding, M B Leader.   

Abstract

BACKGROUND: Chronic hepatitis C virus infection associated with contaminated anti-D immunoglobulin has become an issue of recent concern. The clinical course of chronic hepatitis C infection is unpredictable and histological assessment is felt to be the most reliable means of assessing disease status. Semiquantitative scoring systems have been devised, which assess degree of necroinflammatory disease activity (grade) and extent of disease progression with fibrosis (stage) in chronic hepatitis. Often, using these systems, biopsies of anti-D associated chronic hepatitis C cases show mild changes only, with low scores. The significance of these low scores is uncertain. AIMS: To evaluate the significance of low scores in chronic hepatitis.
METHODS: Liver biopsies were assessed from two groups of patients in whom liver histology would be expected to be normal: 30 cases of Gilbert's syndrome and 13 necropsy cases of young people (< 45 years) with no history or risk factors for liver disease. These biopsies were scored using the histological activity index of Knodell et al and its recent modification (separation of scores for grade and stage) by Ishak et al.
RESULTS: Twenty of 30 cases of Gilbert's syndrome and 11 of the 13 necropsy cases had chronic hepatitis scores of 1 or 2, whereas only eight cases of Gilbert's and two necropsy cases had scores of 0. The remaining two Gilbert's cases had scores of 3 and 5. Similar results were found using both the histological activity index of Knodell et al and the method of Ishak et al.
CONCLUSION: The finding of low but positive scores using these systems in people with normal liver histology questions the reliability and significance of finding such scores in patients with chronic hepatitis and is of particular concern in the evaluation of chronic hepatitis C infection.

Entities:  

Mesh:

Year:  1997        PMID: 9462242      PMCID: PMC500317          DOI: 10.1136/jcp.50.11.929

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

Authors:  R D Goldin; J G Goldin; A D Burt; P A Dhillon; S Hubscher; J Wyatt; N Patel
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 2.  Chronic hepatitis: what is activity and how should it be assessed?

Authors:  P J Scheuer
Journal:  Histopathology       Date:  1997-02       Impact factor: 5.087

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

  4 in total
  3 in total

1.  Modulation of cancer signalling pathway(s) in two -stage mouse skin tumorigenesis by annonacin.

Authors:  Mohd Rohaizad Md Roduan; Roslida Abd Hamid; Norhafizah Mohtarrudin
Journal:  BMC Complement Altern Med       Date:  2019-09-03       Impact factor: 3.659

2.  Evaluation of a Probability-Based Predictive Tool on Pathologist Agreement Using Urinary Bladder as a Pilot Tissue.

Authors:  Emily Jones; Solomon Woldeyohannes; Fernanda Castillo-Alcala; Brandon N Lillie; Mee-Ja M Sula; Helen Owen; John Alawneh; Rachel Allavena
Journal:  Vet Sci       Date:  2022-07-18

Review 3.  Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort.

Authors:  Jamie A Sugrue; Cliona O'Farrelly
Journal:  Pathogens       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.